New Zealand markets close in 3 hours 45 minutes

Sonoma Pharmaceuticals, Inc. (SNOA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.2830-0.0270 (-0.82%)
At close: 04:00PM EDT
3.5400 +0.26 (+7.83%)
After hours: 05:57PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2022
31/03/2021
31/03/2020
31/03/2019
Total revenue
12,628
12,628
18,629
18,936
18,970
Cost of revenue
8,635
8,635
12,070
10,603
10,090
Gross profit
3,993
3,993
6,559
8,333
8,880
Operating expenses
Research development
125
125
555
1,339
1,518
Selling general and administrative
9,755
9,755
9,453
13,665
18,620
Total operating expenses
9,880
9,880
10,008
15,004
20,138
Operating income or loss
-5,887
-5,887
-3,449
-6,671
-11,258
Interest expense
-
-
12
16
33
Total other income/expenses net
479
479
-457
3,812
-239
Income before tax
-5,418
-5,418
-3,902
-2,825
-11,340
Income tax expense
-332
-332
713
121
458
Income from continuing operations
-5,086
-5,086
-4,615
-2,946
-11,798
Net income
-5,086
-5,086
-3,950
-2,946
-11,798
Net income available to common shareholders
-5,086
-5,086
-3,950
-2,946
-11,798
Basic EPS
-
-1.92
-1.97
-1.99
-12.77
Diluted EPS
-
-1.92
-1.97
-1.99
-12.77
Basic average shares
-
2,653
1,996
1,477
923.999
Diluted average shares
-
2,653
1,996
1,477
923.999
EBITDA
-
-5,701
-3,663
-2,497
-10,854